Which anti‑tuberculosis drug is associated with optic neuritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Answer

Ethambutol is the anti‑TB drug most classically associated with optic neuritis (optic neuropathy). 1, 2

  • Mechanism and risk:
    • Dose-related optic toxicity (reduced visual acuity, red–green dyschromatopsia, scotomata), with higher risk at ≥25–30 mg/kg/day and in renal insufficiency; often reversible if stopped promptly 1, 2.
  • Action to protect morbidity/quality of life:
    • Before and during EMB: baseline Snellen and Ishihara; ask monthly about visual changes; do monthly testing if higher dose, use >2 months, or renal impairment; stop EMB immediately and permanently if visual toxicity is suspected 1.
  • Caveats/pitfalls:
    • Linezolid can also cause optic neuritis; if it occurs while on both ethambutol and linezolid, stop both; do not rechallenge ethambutol; linezolid may be cautiously rechallenged after recovery 2.
    • Risk is increased in renal disease—adjust dosing/interval and give after dialysis when applicable to avoid preventable vision loss 1.

References

Guideline

treatment of tuberculosis.

MMWR Recommendations and Reports, 2003

Guideline

treatment of drug-resistant tuberculosis. an official ats/cdc/ers/idsa clinical practice guideline.

American Journal of Respiratory and Critical Care Medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.